Cite
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials.
MLA
Pullen, Matthew F., et al. “Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials.” Clinical Infectious Diseases, vol. 71, no. 7, Oct. 2020, pp. e45–49. EBSCOhost, https://doi.org/10.1093/cid/ciaa016.
APA
Pullen, M. F., Hullsiek, K. H., Rhein, J., Musubire, A. K., Tugume, L., Nuwagira, E., Abassi, M., Ssebambulidde, K., Mpoza, E., Kiggundu, R., Akampurira, A., Nabeta, H. W., Schutz, C., Evans, E. E., Rajasingham, R., Skipper, C. P., Pastick, K. A., Williams, D. A., Morawski, B. M., & Bangdiwala, A. S. (2020). Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials. Clinical Infectious Diseases, 71(7), e45–e49. https://doi.org/10.1093/cid/ciaa016
Chicago
Pullen, Matthew F, Katherine Huppler Hullsiek, Joshua Rhein, Abdu K Musubire, Lillian Tugume, Edwin Nuwagira, Mahsa Abassi, et al. 2020. “Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials.” Clinical Infectious Diseases 71 (7): e45–49. doi:10.1093/cid/ciaa016.